368 related articles for article (PubMed ID: 19335070)
1. Wnt signaling as a therapeutic target for bone diseases.
Hoeppner LH; Secreto FJ; Westendorf JJ
Expert Opin Ther Targets; 2009 Apr; 13(4):485-96. PubMed ID: 19335070
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.
Baron R; Rawadi G
Endocrinology; 2007 Jun; 148(6):2635-43. PubMed ID: 17395698
[TBL] [Abstract][Full Text] [Related]
3. [Wnt signaling and glucocorticoid-induced osteoporosis].
Ohnaka K
Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
[TBL] [Abstract][Full Text] [Related]
4. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.
Beier EE; Sheu TJ; Dang D; Holz JD; Ubayawardena R; Babij P; Puzas JE
J Biol Chem; 2015 Jul; 290(29):18216-18226. PubMed ID: 25975268
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
6. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
Yavropoulou MP; Yovos JG
Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
[TBL] [Abstract][Full Text] [Related]
7. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
8. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
[TBL] [Abstract][Full Text] [Related]
9. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
Lu W; Liu CC; Thottassery JV; Bu G; Li Y
Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
[TBL] [Abstract][Full Text] [Related]
11. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
Marie PJ; Kassem M
Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
[TBL] [Abstract][Full Text] [Related]
12. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
Glass DA; Karsenty G
Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
[TBL] [Abstract][Full Text] [Related]
13. In vivo analysis of Wnt signaling in bone.
Glass DA; Karsenty G
Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
[TBL] [Abstract][Full Text] [Related]
14. The promise of canonical Wnt signaling modulators in enhancing bone repair.
Gregory CA; Green A; Lee N; Rao A; Gunn W
Drug News Perspect; 2006 Oct; 19(8):445-52. PubMed ID: 17160144
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.
Ke HZ; Richards WG; Li X; Ominsky MS
Endocr Rev; 2012 Oct; 33(5):747-83. PubMed ID: 22723594
[TBL] [Abstract][Full Text] [Related]
16. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling control of bone cell apoptosis.
Bodine PV
Cell Res; 2008 Feb; 18(2):248-53. PubMed ID: 18212734
[TBL] [Abstract][Full Text] [Related]
18. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
Semënov M; Tamai K; He X
J Biol Chem; 2005 Jul; 280(29):26770-5. PubMed ID: 15908424
[TBL] [Abstract][Full Text] [Related]
19. [Cytokines in bone diseases. Wnt signal and excessive bone formation].
Hosoi T
Clin Calcium; 2010 Oct; 20(10):1526-31. PubMed ID: 20890035
[TBL] [Abstract][Full Text] [Related]
20. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
